Skip to main content

Table 5 MiRNA-based therapeutics to target tumor angiogenesis

From: New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications

miRNAs

Delivery systems

Cancer

Targets

Ref

miR-125b

PEI

lung cancer, colorectal cancer

VE-cadherin

[85]

miR-192

DOPC

ovarian cancer, renal tumor

EGR1, HOXB9

[116]

miR-200

DOPC

lung cancer, ovarian cancer, renal cancer

IL8, CXCL1

[117]

miR-520d

DOPC

ovarian cancer

EphA2

[118]

miR-132

cRGD

breast cancer

p120RasGAP

[86]

miR-499

APRPG-PEG

colorectal cancer

VEGF

[122]

miR-29a/c

CMVs

gastric cancer

VEGF

[127]

miR-150

CMVs

sarcoma

VEGF

[128]

  1. PEI polymer polyethylenimine, DOPC 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine, cRGD cyclicArginine-Glycine-Aspartic acid, APRPG-PEG Ala-Pro-Arg-Pro-Glypeptide-conjugated polyethyleneglycol, CMVs Cell-derived membrane vesicles